Certara Operating Margin from 2010 to 2025
| CERT Stock | USD 10.32 0.46 4.27% |
Check Certara financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Certara's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 18.3 M or Selling General Administrative of 81.8 M, as well as many indicators such as Price To Sales Ratio of 4.21, Dividend Yield of 0.0 or PTB Ratio of 1.53. Certara financial statements analysis is a perfect complement when working with Certara Valuation or Volatility modules.
Certara | Operating Margin |
Latest Certara's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Certara over the last few years. It is Certara's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Certara's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.14 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Certara Operating Margin Regression Statistics
| Arithmetic Mean | (0.02) | |
| Coefficient Of Variation | (371.08) | |
| Mean Deviation | 0.04 | |
| Median | (0.03) | |
| Standard Deviation | 0.06 | |
| Sample Variance | 0 | |
| Range | 0.212 | |
| R-Value | 0.17 | |
| Mean Square Error | 0 | |
| R-Squared | 0.03 | |
| Significance | 0.53 | |
| Slope | 0 | |
| Total Sum of Squares | 0.05 |
Certara Operating Margin History
About Certara Financial Statements
Certara shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Certara investors may analyze each financial statement separately, they are all interrelated. The changes in Certara's assets and liabilities, for example, are also reflected in the revenues and expenses on on Certara's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. Certara operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1054 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Certara Stock Analysis
When running Certara's price analysis, check to measure Certara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Certara is operating at the current time. Most of Certara's value examination focuses on studying past and present price action to predict the probability of Certara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Certara's price. Additionally, you may evaluate how the addition of Certara to your portfolios can decrease your overall portfolio volatility.